Vertex Pharmaceuticals Inc (VRTX)
Days of inventory on hand (DOH)
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inventory turnover | 2.53 | 2.76 | 3.05 | 3.22 | 3.31 | 3.29 | 3.67 | 3.97 | 4.51 | 5.23 | 5.24 | 5.53 | 5.09 | 4.97 | 4.95 | 5.17 | 5.37 | 6.00 | 6.41 | 7.06 | |
DOH | days | 144.45 | 132.47 | 119.51 | 113.25 | 110.37 | 111.06 | 99.35 | 92.00 | 80.98 | 69.84 | 69.64 | 66.05 | 71.75 | 73.47 | 73.70 | 70.54 | 68.02 | 60.86 | 56.94 | 51.69 |
December 31, 2024 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 2.53
= 144.45
Based on the provided data for Vertex Pharmaceuticals Inc, the days of inventory on hand (DOH) have shown an increasing trend over the last few years. The DOH has increased from 51.69 days as of March 31, 2020, to 144.45 days as of December 31, 2024.
A high DOH indicates that the company is taking a longer time to sell its inventory, which could potentially lead to higher carrying costs and obsolescence risks. It is crucial for companies to strike a balance between maintaining optimal inventory levels to meet demand and avoiding excessive inventory levels that tie up capital and resources.
The significant increase in DOH observed for Vertex Pharmaceuticals Inc suggests a need for closer monitoring and management of inventory levels to ensure efficient operations. The company may need to evaluate its inventory management strategies, demand forecasting techniques, production planning processes, and supply chain efficiencies to address the rising DOH trend and optimize its inventory turnover.
Peer comparison
Dec 31, 2024
See also:
Vertex Pharmaceuticals Inc Average Inventory Processing Period (Quarterly Data)